CFO interim
Cadrenal Therapeutics, Inc. names Quang X. Pham interim CFO
Cadrenal Therapeutics, Inc. reported in a Form 8-K filed June 3, 2026 that Quang X. Pham was named interim interim Chief Financial Officer and interim Principal Accounting Officer, effective May 28, 2026.
In the filing's words
Effective immediately after Mr. Szot’s termination, the Company appointed Quang X. Pham, its Chief Executive Officer, as interim Chief Financial Officer and interim Principal Accounting Officer, to serve until a permanent Chief Financial Officer is appointed.
Verbatim from sec.gov, Item 5.02. We quote departures; we do not characterize them.
| Company | Cadrenal Therapeutics, Inc. (CVKD) |
|---|---|
| Event | Interim |
| Incoming | Quang X. Pham |
| Outgoing | Matthew K. Szot |
| Title in the filing | interim Chief Financial Officer and interim Principal Accounting Officer |
| Effective | May 28, 2026 |
| 8-K filed | June 3, 2026 |
| Internal promotion | Yes |
| Prior role (per filing) | Chief Executive Officer, Cadrenal Therapeutics, Inc. |
| SEC CIK | 0001937993 |
Cadrenal Therapeutics, Inc. reported this change in a Form 8-K, Item 5.02, filed June 3, 2026. The filing's own words are quoted above.
Sources
- sec.gov · SEC filing, Item 5.02 · accessed 2026-09-26
Something wrong about Quang X. Pham? Send a correction with the primary source.